Chris Smith began his tenure at Genova Diagnostics in 2006 as Vice President of Sales and Marketing. His performance in that role has directly contributed to the overall growth of Genova Diagnostics and in June 2015, the Board of Directors appointed Chris to President and Chief Executive Officer.
Chris possesses more than 20 years of experience in the laboratory services industry within the areas of laboratory operations, business development, sales, and marketing. His broad background has allowed him first hand knowledge of operations, financial management and new market development. He has contributed to the overall growth of the laboratories he has worked for by consistently focusing on process improvements, operational excellence and successful execution of commercial growth strategies. As CEO, he leverages this background to lead Genova Diagnostics in our mission to be the best provider of laboratory services for the treatment of complex chronic disease.
Prior to joining Genova Diagnostics, Chris held positions of increasing seniority with healthcare and biotechnology firms, including GeneScreen, Inc, Pathology Partners and functioned as the senior manager responsible for sales and marketing in the Americas for Orchid Cellmark. Chris has an undergraduate science degree and holds an MBA from the Mays School of Business at Texas A&M University.